British Columbia Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.82M | Buy |
86,467
+6,489
| +8% | +$544K | 0.05% | 301 |
|
|
2026
Q1 | $6.4M | Sell |
79,978
-24,211
| -23% | -$2M | 0.04% | 322 |
|
|
2025
Q4 | $8.88M | Buy |
104,189
+19,887
| +24% | +$1.63M | 0.05% | 287 |
|
|
2025
Q3 | $6.56M | Sell |
84,302
-7,863
| -9% | -$614K | 0.04% | 314 |
|
|
2025
Q2 | $7.21M | Sell |
92,165
-20,629
| -18% | -$1.54M | 0.04% | 290 |
|
|
2025
Q1 | $8.18M | Sell |
112,794
-2,572
| -2% | -$184K | 0.05% | 294 |
|
|
2024
Q4 | $8.54M | Buy |
115,366
+14,831
| +15% | +$1.04M | 0.05% | 299 |
|
|
2024
Q3 | $6.63M | Sell |
100,535
-14,632
| -13% | -$1.06M | 0.04% | 319 |
|
|
2024
Q2 | $10.6M | Buy |
115,167
+42,527
| +59% | +$3.77M | 0.06% | 230 |
|
|
2024
Q1 | $6.94M | Buy |
72,640
+2,670
| +4% | +$224K | 0.05% | 267 |
|
|
2023
Q4 | $5.34M | Buy |
69,970
+14,814
| +27% | +$1.03M | 0.04% | 287 |
|
|
2023
Q3 | $3.82M | Buy |
55,156
+483
| +0.9% | +$38.8K | 0.04% | 306 |
|
|
2023
Q2 | $5.16M | Sell |
54,673
-497
| -0.9% | -$43.2K | 0.05% | 263 |
|
|
2023
Q1 | $4.56M | Buy |
55,170
+246
| +0.4% | +$19.3K | 0.05% | 275 |
|
|
2022
Q4 | $4.1M | Sell |
54,924
-6,685
| -11% | -$515K | 0.04% | 289 |
|
|
2022
Q3 | $5.09M | Sell |
61,609
-10,815
| -15% | -$1.04M | 0.06% | 261 |
|
|
2022
Q2 | $6.89M | Sell |
72,424
-23,961
| -25% | -$2.48M | 0.07% | 249 |
|
|
2022
Q1 | $11.3M | Sell |
96,385
-13,105
| -12% | -$1.47M | 0.07% | 226 |
|
|
2021
Q4 | $14.2M | Sell |
109,490
-5,514
| -5% | -$643K | 0.08% | 220 |
|
|
2021
Q3 | $13M | Sell |
115,004
-664
| -0.6% | -$75.8K | 0.08% | 229 |
|
|
2021
Q2 | $12M | Sell |
115,668
-225,509
| -66% | -$21.3M | 0.07% | 249 |
|
|
2021
Q1 | $28.5M | Buy |
341,177
+19,695
| +6% | +$1.67M | 0.21% | 88 |
|
|
2020
Q4 | $29.3M | Buy |
321,482
+26,687
| +9% | +$2.21M | 0.21% | 97 |
|
|
2020
Q3 | $23.5M | Buy |
294,795
+41,347
| +16% | +$3.23M | 0.19% | 104 |
|
|
2020
Q2 | $17.5M | Buy |
253,448
+185,003
| +270% | +$13.1M | 0.17% | 111 |
|
|
2020
Q1 | $4.3M | Sell |
68,445
-78,777
| -54% | -$5.68M | 0.07% | 235 |
|
|
2019
Q4 | $11.4M | Sell |
147,222
-107,472
| -42% | -$8.39M | 0.09% | 205 |
|
|
2019
Q3 | $18.7M | Sell |
254,694
-18,402
| -7% | -$1.29M | 0.18% | 120 |
|
|
2019
Q2 | $16.8M | Buy |
273,096
+101,148
| +59% | +$6.12M | 0.15% | 144 |
|
|
2019
Q1 | $11M | Sell |
171,948
-68,880
| -29% | -$3.93M | 0.1% | 201 |
|
|
2018
Q4 | $12.3M | Sell |
240,828
-84,420
| -26% | -$4.27M | 0.11% | 198 |
|
|
2018
Q3 | $18.9M | Sell |
325,248
-63,684
| -16% | -$3.11M | 0.2% | 111 |
|
|
2018
Q2 | $18.9M | Sell |
388,932
-123,705
| -24% | -$5.77M | 0.17% | 137 |
|
|
2018
Q1 | $23.8M | Sell |
512,637
-63,198
| -11% | -$2.74M | 0.18% | 129 |
|
|
2017
Q4 | $21.6M | Buy |
575,835
+60,453
| +12% | +$2.22M | 0.15% | 166 |
|
|
2017
Q3 | $18.8M | Sell |
515,382
-16,182
| -3% | -$617K | 0.15% | 181 |
|
|
2017
Q2 | $21M | Buy |
531,564
+152,256
| +40% | +$5.56M | 0.17% | 151 |
|
|
2017
Q1 | $11.9M | Sell |
379,308
-4,470
| -1% | -$140K | 0.09% | 266 |
|
|
2016
Q4 | $12M | Sell |
383,778
-14,364
| -4% | -$465K | 0.11% | 220 |
|
|
2016
Q3 | $16M | Sell |
398,142
-39,204
| -9% | -$1.48M | 0.16% | 149 |
|
|
2016
Q2 | $14.5M | Buy |
437,346
+45,873
| +12% | +$1.57M | 0.13% | 185 |
|
|
2016
Q1 | $11.5M | Buy |
391,473
+75,459
| +24% | +$2.08M | 0.11% | 221 |
|
|
2015
Q4 | $8.32M | Buy |
316,014
+18,678
| +6% | +$485K | 0.08% | 286 |
|
|
2015
Q3 | $7.04M | Sell |
297,336
-56,394
| -16% | -$1.36M | 0.07% | 313 |
|
|
2015
Q2 | $8.4M | Sell |
353,730
-213,378
| -38% | -$4.82M | 0.08% | 306 |
|
|
2015
Q1 | $13.5M | Buy |
567,108
+183,864
| +48% | +$4.12M | 0.12% | 221 |
|
|
2014
Q4 | $8.14M | Sell |
383,244
-2,982
| -0.8% | -$59.9K | 0.07% | 344 |
|
|
2014
Q3 | $6.58M | Sell |
386,226
-38,634
| -9% | -$610K | 0.06% | 359 |
|
|
2014
Q2 | $6.08M | Sell |
424,860
-28,638
| -6% | -$388K | 0.05% | 394 |
|
|
2014
Q1 | $5.61M | Sell |
453,498
-49,578
| -10% | -$572K | 0.05% | 404 |
|
|
2013
Q4 | $5.51M | Sell |
503,076
-32,148
| -6% | -$362K | 0.04% | 411 |
|
|
2013
Q3 | $6.21M | Sell |
535,224
-73,884
| -12% | -$864K | 0.05% | 391 |
|
|
2013
Q2 | $6.82M | Buy |
+609,108
| New | +$7.21M | 0.06% | 378 |
|
Other funds holding EW
British Columbia Investment Management's EW Position: Q2 2026 in Review
British Columbia Investment Management increased its Edwards Lifesciences (EW) stake by 8.1% in Q2 2026, buying an estimated $544K and bringing the position to 86,467 shares worth $7.82M. The position accounts for 0.05% of the portfolio, ranked #301.
British Columbia Investment Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.3M in Q4 2020. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- British Columbia Investment Management held 86,467 shares of Edwards Lifesciences worth $7.82M as of Q2 2026.
- British Columbia Investment Management bought 6,489 Edwards Lifesciences shares in Q2 2026, an estimated $544K.
- Edwards Lifesciences made up 0.05% of British Columbia Investment Management's portfolio in Q2 2026, its #301 holding.
- British Columbia Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- British Columbia Investment Management's Edwards Lifesciences position peaked at $29.3M in Q4 2020.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.